Nov 1 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO
* Valeant Pharmaceuticals comments on press report regarding its gastroenterology business unit
* Valeant Pharmaceuticals international inc - currently in discussions with third parties for various divestitures including but not limited to Salix
* Says discussions may or may not lead to a definitive agreement Source text for Eikon: ID:nCNW0shjba Further company coverage: VRX.TO